InsiderTrades.com logo

VNDA Insider Trading

Insider Ownership Percentage: 10.00%
Insider Buying (Last 12 Months): $279,580.00
Insider Selling (Last 12 Months): $32,130.00

Vanda Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Vanda Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vanda Pharmaceuticals Share Price & Price History

Current Price: $5.20
Price Change: ▼ Price Decrease of -0.07 (-1.33%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for VNDA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Vanda Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/13/2025Stephen Ray MitchellDirectorSell7,000$4.59$32,130.0097,082View SEC Filing Icon  
5/21/2025Mihael Hristos PolymeropoulosCEOBuy10,000$4.40$44,000.002,325,731View SEC Filing Icon  
5/16/2025Mihael Hristos PolymeropoulosCEOBuy20,000$4.22$84,400.002,315,731View SEC Filing Icon  
3/5/2025Mihael Hristos PolymeropoulosCEOBuy10,000$5.02$50,200.002,285,731View SEC Filing Icon  
2/28/2025Mihael Hristos PolymeropoulosCEOBuy10,000$4.76$47,600.002,361,730View SEC Filing Icon  
2/25/2025Mihael Hristos PolymeropoulosCEOBuy10,000$4.46$44,600.002,331,730View SEC Filing Icon  
2/21/2025Kevin Patrick MoranCFOBuy2,000$4.39$8,780.00355,763View SEC Filing Icon  
11/14/2024Stephen Ray MitchellDirectorSell5,000$5.17$25,850.0044,857View SEC Filing Icon  
7/29/2024Kevin Patrick MoranCFOSell2,251$5.92$13,325.92228,763View SEC Filing Icon  
8/21/2023Joakim WijkstromCMOSell3,724$5.84$21,748.16113,816View SEC Filing Icon  
8/10/2023Stephen Ray MitchellDirectorSell6,500$6.05$39,325.0029,328View SEC Filing Icon  
7/28/2023Kevin Patrick MoranCFOSell2,212$6.30$13,935.60120,714View SEC Filing Icon  
6/15/2023Kevin Patrick MoranCFOSell16,000$6.29$100,640.00122,926View SEC Filing Icon  
6/13/2023Timothy WilliamsSVPSell14,600$6.56$95,776.0088,913View SEC Filing Icon  
3/2/2023Joakim WijkstromCMOSell7,720$6.23$48,095.60121,653View SEC Filing Icon  
3/2/2023Kevin Patrick MoranCFOSell7,966$6.26$49,867.16144,894View SEC Filing Icon  
3/2/2023Mihael Hristos PolymeropoulosCEOSell22,426$6.23$139,713.981,499,440View SEC Filing Icon  
3/2/2023Timothy WilliamsSVPSell8,437$6.24$52,646.88111,814View SEC Filing Icon  
12/15/2022Timothy WilliamsSVPSell8,000$7.01$56,080.0087,551View SEC Filing Icon  
12/6/2022Kevin Patrick MoranCFOSell4,792$10.61$50,843.12120,160View SEC Filing Icon  
12/5/2022Mihael Hristos PolymeropoulosCEOSell47,650$10.62$506,043.001,379,751View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Vanda Pharmaceuticals (NASDAQ:VNDA)

88.14% of Vanda Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VNDA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Vanda Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Jacobs Levy Equity Management Inc.108,610$0.54M0.0%-34.6%0.184%Search for SEC Filing on Google Icon
11/17/2025Krensavage Asset Management LLC1,180,388$5.89M2.5%+15.2%1.997%Search for SEC Filing on Google Icon
11/17/2025PharVision Advisers LLC57,037$0.29M0.2%N/A0.097%Search for SEC Filing on Google Icon
11/17/2025Susquehanna Fundamental Investments LLC15,137$76K0.0%-36.2%0.026%Search for SEC Filing on Google Icon
11/17/2025Quarry LP10,702$53K0.0%N/A0.018%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd179,252$0.89M0.0%N/A0.303%Search for SEC Filing on Google Icon
11/17/2025Public Employees Retirement System of Ohio21,222$0.11M0.0%-35.5%0.036%Search for SEC Filing on Google Icon
11/17/2025Nomura Holdings Inc.30,487$0.15M0.0%-23.9%0.052%Search for SEC Filing on Google Icon
11/17/2025Mercer Global Advisors Inc. ADV28,993$0.15M0.0%N/A0.049%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.26,138$0.13M0.0%-14.3%0.044%Search for SEC Filing on Google Icon
11/17/2025Lido Advisors LLC10,100$50K0.0%-21.6%0.017%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE106,436$0.53M0.0%-28.8%0.180%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC14,446$72K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC34,934$0.17M0.0%N/A0.059%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.29,492$0.15M0.0%-57.1%0.050%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP662,305$3.31M0.0%+25.7%1.121%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC114,554$0.57M0.0%-25.3%0.194%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG126,116$0.63M0.0%+80.6%0.213%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets65,535$0.33M0.0%+629.9%0.111%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.6,495$32K0.0%+456.6%0.011%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP2,563,969$12.79M0.0%-0.8%4.339%Search for SEC Filing on Google Icon
11/10/2025Monaco Asset Management SAM247,805$1.24M0.1%-18.8%0.419%Search for SEC Filing on Google Icon
11/7/2025Readystate Asset Management LP27,610$0.14M0.0%N/A0.047%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP318,799$1.59M0.1%-16.6%0.539%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.3,587,139$17.90M0.0%+0.4%6.070%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.199,893$1M0.0%+16.5%0.338%Search for SEC Filing on Google Icon
11/5/2025Alps Advisors Inc.27,925$0.14M0.0%-12.1%0.047%Search for SEC Filing on Google Icon
11/5/2025Savant Capital LLC22,493$0.11M0.0%+30.3%0.038%Search for SEC Filing on Google Icon
11/4/2025State of Wyoming27,301$0.14M0.0%N/A0.046%Search for SEC Filing on Google Icon
11/3/2025Federated Hermes Inc.681,836$3.40M0.0%-6.4%1.154%Search for SEC Filing on Google Icon
10/29/2025Inscription Capital LLC16,232$81K0.0%N/A0.027%Search for SEC Filing on Google Icon
10/29/2025Wealth Enhancement Advisory Services LLC17,500$93K0.0%N/A0.030%Search for SEC Filing on Google Icon
10/15/2025CWM LLC33,146$0.17M0.0%+254.2%0.056%Search for SEC Filing on Google Icon
10/14/2025Profit Investment Management LLC186,400$0.93M1.2%-43.5%0.315%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC10,899$54K0.0%-33.5%0.018%Search for SEC Filing on Google Icon
8/27/2025Squarepoint Ops LLC153,345$0.72M0.0%+96.5%0.260%Search for SEC Filing on Google Icon
8/15/2025Krensavage Asset Management LLC1,024,883$4.84M2.6%+35.9%1.734%Search for SEC Filing on Google Icon
8/15/2025Engineers Gate Manager LP15,806$75K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets8,979$42K0.0%-72.1%0.015%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE149,471$0.71M0.0%+23.0%0.253%Search for SEC Filing on Google Icon
8/15/2025Ameriprise Financial Inc.68,699$0.32M0.0%-53.5%0.116%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC79,107$0.37M0.0%+6.1%0.134%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.30,495$0.14M0.0%-10.5%0.052%Search for SEC Filing on Google Icon
8/14/2025Sei Investments Co.190,261$0.90M0.0%-40.6%0.322%Search for SEC Filing on Google Icon
8/14/2025Cerity Partners LLC14,668$69K0.0%N/A0.025%Search for SEC Filing on Google Icon
8/13/2025StoneX Group Inc.20,000$94K0.0%N/A0.034%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP471,720$2.23M0.0%+945.9%0.798%Search for SEC Filing on Google Icon
8/13/2025Walleye Capital LLC94,298$0.45M0.0%+155.1%0.160%Search for SEC Filing on Google Icon
8/13/2025Stonepine Capital Management LLC250,000$1.18M1.2%+611.3%0.423%Search for SEC Filing on Google Icon
8/13/2025Kennedy Capital Management LLC237,468$1.12M0.0%+7.7%0.402%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.172,164$0.81M0.0%-16.0%0.291%Search for SEC Filing on Google Icon
8/13/2025Schroder Investment Management Group307,176$1.45M0.0%-53.9%0.520%Search for SEC Filing on Google Icon
8/13/2025Norges Bank115,000$0.54M0.0%N/A0.195%Search for SEC Filing on Google Icon
8/13/2025Hsbc Holdings PLC66,554$0.32M0.0%+17.6%0.113%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd31,524$0.15M0.0%-54.5%0.053%Search for SEC Filing on Google Icon
8/12/2025Prudential Financial Inc.606,003$2.86M0.0%-14.7%1.026%Search for SEC Filing on Google Icon
8/12/2025American Century Companies Inc.139,878$0.66M0.0%-49.8%0.237%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.171,655$0.81M0.0%-51.0%0.290%Search for SEC Filing on Google Icon
8/11/2025Universal Beteiligungs und Servicegesellschaft mbH180,000$0.85M0.0%-5.5%0.305%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC25,763$0.12M0.0%-30.6%0.044%Search for SEC Filing on Google Icon
8/8/2025Bailard Inc.26,100$0.12M0.0%+16.2%0.044%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC1,691,638$7.99M0.0%+4.8%2.863%Search for SEC Filing on Google Icon
8/7/2025Monaco Asset Management SAM305,000$1.44M0.3%-6.2%0.516%Search for SEC Filing on Google Icon
8/7/2025Acadian Asset Management LLC1,731,890$8.17M0.0%-8.2%2.931%Search for SEC Filing on Google Icon
8/7/2025Connor Clark & Lunn Investment Management Ltd.868,419$4.10M0.0%-6.6%1.470%Search for SEC Filing on Google Icon
8/7/2025Los Angeles Capital Management LLC44,696$0.21M0.0%+17.8%0.076%Search for SEC Filing on Google Icon
7/31/2025R Squared Ltd17,556$83K0.0%N/A0.030%Search for SEC Filing on Google Icon
7/25/2025CWM LLC9,359$44K0.0%+424.6%0.016%Search for SEC Filing on Google Icon
7/15/2025Public Employees Retirement System of Ohio32,922$0.16M0.0%-23.3%0.056%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.693,852$3.19M0.0%-11.9%1.177%Search for SEC Filing on Google Icon
6/18/2025Voya Investment Management LLC15,896$73K0.0%-14.0%0.027%Search for SEC Filing on Google Icon
6/4/2025PVG Asset Management Corp10,375$48K0.2%N/A0.018%Search for SEC Filing on Google Icon
5/29/2025Rhumbline Advisers85,899$0.39M0.0%-5.5%0.146%Search for SEC Filing on Google Icon
5/21/2025Acadian Asset Management LLC1,887,049$8.66M0.0%-0.7%3.202%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.693,852$3.19M0.0%-11.9%1.177%Search for SEC Filing on Google Icon
5/16/2025Millennium Management LLC2,139,591$9.82M0.0%+220.0%3.630%Search for SEC Filing on Google Icon
5/16/2025Jacobs Levy Equity Management Inc.274,293$1.26M0.0%-41.7%0.465%Search for SEC Filing on Google Icon
5/15/2025Royal Bank of Canada55,713$0.26M0.0%+34.3%0.095%Search for SEC Filing on Google Icon
5/15/2025Trexquant Investment LP192,110$0.88M0.0%-15.2%0.326%Search for SEC Filing on Google Icon
5/14/2025MetLife Investment Management LLC32,816$0.15M0.0%+18.9%0.056%Search for SEC Filing on Google Icon
5/14/2025Stonepine Capital Management LLC35,148$0.16M0.2%+40.6%0.060%Search for SEC Filing on Google Icon
5/14/2025Walleye Capital LLC36,966$0.17M0.0%N/A0.063%Search for SEC Filing on Google Icon
5/14/2025Martingale Asset Management L P22,909$0.11M0.0%-64.7%0.039%Search for SEC Filing on Google Icon
5/14/2025Hsbc Holdings PLC56,594$0.26M0.0%+17.8%0.096%Search for SEC Filing on Google Icon
5/14/2025Wellington Management Group LLP265,888$1.22M0.0%-23.8%0.451%Search for SEC Filing on Google Icon
5/13/2025Algert Global LLC26,910$0.12M0.0%N/A0.046%Search for SEC Filing on Google Icon
5/13/2025Nations Financial Group Inc. IA ADV14,500$67K0.0%N/A0.025%Search for SEC Filing on Google Icon
5/13/2025American Century Companies Inc.278,791$1.28M0.0%-7.2%0.473%Search for SEC Filing on Google Icon
5/13/2025Russell Investments Group Ltd.16,184$74K0.0%-54.3%0.027%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC440,561$2.02M0.0%N/A0.748%Search for SEC Filing on Google Icon
5/12/2025Virtu Financial LLC15,603$72K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/12/2025Invesco Ltd.204,964$0.94M0.0%-10.2%0.348%Search for SEC Filing on Google Icon
5/12/2025Connor Clark & Lunn Investment Management Ltd.929,644$4.27M0.0%+13.5%1.577%Search for SEC Filing on Google Icon
5/9/2025Deutsche Bank AG62,417$0.29M0.0%-11.0%0.106%Search for SEC Filing on Google Icon
5/9/2025Charles Schwab Investment Management Inc.475,865$2.18M0.0%-14.8%0.807%Search for SEC Filing on Google Icon
5/8/2025Monaco Asset Management SAM325,000$1.49M0.3%-17.1%0.551%Search for SEC Filing on Google Icon
5/8/2025XTX Topco Ltd69,329$0.32M0.0%+378.3%0.118%Search for SEC Filing on Google Icon
5/8/2025GSA Capital Partners LLP260,215$1.19M0.1%+88.0%0.442%Search for SEC Filing on Google Icon
5/6/2025Universal Beteiligungs und Servicegesellschaft mbH190,536$0.88M0.0%N/A0.323%Search for SEC Filing on Google Icon
5/2/2025Bailard Inc.22,469$0.10M0.0%N/A0.038%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Vanda Pharmaceuticals logo
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its pipeline products include HETLIOZ (tasimelteon) to treat jet lag disorder, insomnia, delayed sleep phase disorder, sleep disturbances in autism spectrum disorder, and pediatric Non-24; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist to treat gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia. The company's pipeline products also include VTR-297, a small molecule histone deacetylase inhibitor to treat hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist to treat performance anxiety and psychiatric disorders; VHX-896, an active metabolite of iloperidone; and antisense oligonucleotide molecules. In addition, it offers a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors that include VSJ-110 for the treatment of dry eye and ocular inflammation; and VPO-227 for the treatment of secretory diarrhea disorders comprising cholera. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
Read More on Vanda Pharmaceuticals

Today's Range

Now: $5.20
Low: $5.18
High: $5.33

50 Day Range

MA: $5.02
Low: $4.32
High: $5.61

52 Week Range

Now: $5.20
Low: $3.81
High: $5.70

Volume

938,512 shs

Average Volume

843,935 shs

Market Capitalization

$307.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Who are the company insiders with the largest holdings of Vanda Pharmaceuticals?

Vanda Pharmaceuticals' top insider investors include:
  1. Mihael Hristos Polymeropoulos (CEO)
  2. Kevin Patrick Moran (CFO)
  3. Stephen Ray Mitchell (Director)
Learn More about top insider investors at Vanda Pharmaceuticals.

Who are the major institutional investors of Vanda Pharmaceuticals?

Vanda Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 6.07%
  2. Dimensional Fund Advisors LP — 4.34%
  3. Krensavage Asset Management LLC — 2.00%
  4. Federated Hermes Inc. — 1.15%
  5. Two Sigma Investments LP — 1.12%
  6. GSA Capital Partners LLP — 0.54%
Learn More about top institutional investors of Vanda Pharmaceuticals stock.

Which major investors are selling Vanda Pharmaceuticals stock?

Within the previous quarter, VNDA stock was sold by these institutional investors:
  1. Susquehanna International Group LLP
  2. Profit Investment Management LLC
  3. GSA Capital Partners LLP
  4. Jacobs Levy Equity Management Inc.
  5. Monaco Asset Management SAM
  6. Federated Hermes Inc.
  7. Bank of America Corp DE
  8. Ameriprise Financial Inc.

Which major investors are buying Vanda Pharmaceuticals stock?

In the last quarter, VNDA stock was bought by institutional investors including:
  1. Qube Research & Technologies Ltd
  2. Krensavage Asset Management LLC
  3. Two Sigma Investments LP
  4. Millennium Management LLC
  5. PharVision Advisers LLC
  6. BNP Paribas Financial Markets
  7. UBS Group AG
  8. Algert Global LLC
Within the last year, these company insiders have bought Vanda Pharmaceuticals stock:
  1. Mihael Hristos Polymeropoulos (CEO)
  2. Kevin Patrick Moran (CFO)
Learn More investors buying Vanda Pharmaceuticals stock.